[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Costa M.I., Sarmento-Ribeiro A.B., Gonalves A.C
If you are experiencing side effects during a dose escalation, stay on the low FDA-approved doses for a longer duration to avoid these side effects
33 In a phase 2 open-label study, NGM282 improved the histological features of MASH within 12 weeks, demonstrating significant reductions in NAS and fibrosis scores, along with improvements in noninvasive imaging and serum markers
Obesity 17 , 17361743 (2009)
doi: 10.1519/1533-4287(2003)017 2.0.co;2
She also said weight regain is possible after stopping the medication, meaning long-term or even lifelong use may be needed to maintain results